...
机译:Neoadjuvant化疗治疗胰腺导管腺癌患者肿瘤浸润淋巴细胞的预后意义
Univ Texas MD Anderson Canc Ctr Dept Pathol Unit 085 1515 Holcombe Blvd Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Gastrointestinal Med Oncol 1515 Holcombe Blvd Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Gastrointestinal Med Oncol 1515 Holcombe Blvd Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Gastrointestinal Med Oncol 1515 Holcombe Blvd Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Pathol Unit 085 1515 Holcombe Blvd Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Pathol Unit 085 1515 Holcombe Blvd Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Translat Mol Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Translat Mol Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Translat Mol Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Pathol Unit 085 1515 Holcombe Blvd Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Gastrointestinal Med Oncol 1515 Holcombe Blvd Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Gastrointestinal Med Oncol 1515 Holcombe Blvd Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Pathol Unit 085 1515 Holcombe Blvd Houston TX 77030 USA;
CD4; CD8; FOXP3; pancreatic cancer; prognosis; tumor-infiltrating lymphocytes;
机译:Neoadjuvant化疗治疗胰腺导管腺癌患者肿瘤浸润淋巴细胞的预后意义
机译:Neoadjuvant化疗治疗腔B / SER 2阴性乳腺癌患者CD8(+)肿瘤肿瘤淋巴细胞的预测性和预测意义
机译:新辅助治疗治疗胰腺导管腺癌患者新AJCC肿瘤阶段的预后意义
机译:纹理分析对胰腺癌新辅助化疗患者生存率的预测
机译:Ca19-9抗原和stra聚糖定义独立的胰腺导管腺癌群,提高了预后分类的诊断准确性和方法
机译:新辅助化学疗法治疗胰腺导管腺癌患者肿瘤浸润淋巴细胞的预后意义
机译:Neoadjuvant化疗治疗胰腺导管腺癌患者肿瘤浸润淋巴细胞的预后意义